Perfluorinated compounds differentially affect steroidogenesis and viability in the human adrenocortical carcinoma (H295R) in vitro cell assay

Toxicology Letters

Volumn 205, Issue 1, 2011, Pages 62-68

  Kraugerud, Marianne ^a   Zimmer, Karin E ^a   Ropstad, Erik ^a   Verhaegen, Steven ^a  

^a NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

Author keywords

Apoptosis; Endocrine disruption; H295R; Perfluorononanoic acid; Perfluorooctane sulfonate; Perfluorooctanoic acid

Indexed keywords

AROMATASE; CHOLESTEROL MONOOXYGENASE (SIDE CHAIN CLEAVING); ESTRADIOL; PERFLUORONONANOIC ACID; PERFLUOROOCTANESULFONIC ACID; PERFLUOROOCTANOIC ACID; PROGESTERONE; STEROID HORMONE; TESTOSTERONE;

ADRENAL CORTEX CARCINOMA; APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL ASSAY; CELL DEATH; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; ESTRADIOL BLOOD LEVEL; FLOW CYTOMETRY; FLUORINATION; GENE EXPRESSION; HORMONE SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIOIMMUNOASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEROIDOGENESIS; TESTOSTERONE RELEASE;

ADRENAL CORTEX NEOPLASMS; ALKANESULFONIC ACIDS; AROMATASE; CELL DEATH; CELL LINE, TUMOR; CELL SURVIVAL; CHOLESTEROL SIDE-CHAIN CLEAVAGE ENZYME; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; FLUOROCARBONS; FORSKOLIN; HUMANS; OCTANOIC ACIDS; PROPIDIUM; RADIOIMMUNOASSAY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; STEROIDS;

EID: 79959955425     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2011.05.230     Document Type: Article

References (38)

1. AMAP, 2009. Arctic Pollution 2009. Arctic Monitoring and Assessment Programme, Oslo. xi+83 pp.
2. Andersen C.S., Fei C., Gamborg M., Nohr E.A., Sorensen T.I., Olsen J. Prenatal exposures to perfluorinated chemicals and anthropometric measures in infancy. Am. J. Epidemiol. 2010, 172:1230-1237.
3. Apelberg B.J., Witter F.R., Herbstman J.B., Calafat A.M., Halden R.U., Needham L.L., Goldman L.R. Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth. Environ. Health Perspect. 2007, 115:1670-1676.
4. Biegel L.B., Hurtt M.E., Frame S.R., O'Connor J.C., Cook J.C. Mechanisms of extrahepatic tumor induction by peroxisome proliferators in male CD rats. Toxicol. Sci. 2001, 60:44-55.
5. Biegel L.B., Liu R.C., Hurtt M.E., Cook J.C. Effects of ammonium perfluorooctanoate on Leydig cell function: in vitro, in vivo, and ex vivo studies. Toxicol. Appl. Pharmacol. 1995, 134:18-25.
6. Boujrad N., Vidic B., Gazouli M., Culty M., Papadopoulos V. The peroxisome proliferator perfluorodecanoic acid inhibits the peripheral-type benzodiazepine receptor (PBR) expression and hormone-stimulated mitochondrial cholesterol transport and steroid formation in Leydig cells. Endocrinology 2000, 141:3137-3148.
7. Case M.T., York R.G., Christian M.S. Rat and rabbit oral developmental toxicology studies with two perfluorinated compounds. Int. J. Toxicol. 2001, 20:101-109.
8. Cook J.C., Murray S.M., Frame S.R., Hurtt M.E. Induction of Leydig cell adenomas by ammonium perfluorooctanoate: a possible endocrine-related mechanism. Toxicol. Appl. Pharmacol. 1992, 113:209-217.
9. Fang X., Feng Y., Shi Z., Dai J. Alterations of cytokines and MAPK signaling pathways are related to the immunotoxic effect of perfluorononanoic acid. Toxicol. Sci. 2009, 108:367-376.
10. Fang X., Zhang L., Feng Y., Zhao Y., Dai J. Immunotoxic effects of perfluorononanoic acid on BALB/c mice. Toxicol. Sci. 2008, 105:312-321.
11. Fei C., McLaughlin J.K., Tarone R.E., Olsen J. Fetal growth indicators and perfluorinated chemicals: a study in the Danish National Birth Cohort. Am. J. Epidemiol. 2008, 168:66-72.
12. Feng Y., Shi Z., Fang X., Xu M., Dai J. Perfluorononanoic acid induces apoptosis involving the Fas death receptor signaling pathway in rat testis. Toxicol. Lett. 2009.
13. Fernandez F.P., Perez Martin J.M., Herrero O., Peropadre A., de la P.E., Hazen M.J. In vitro assessment of the cytotoxic and mutagenic potential of perfluorooctanoic acid. Toxicol. In Vitro 2008, 22:1228-1233.
14. Fromme H., Tittlemier S.A., Volkel W., Wilhelm M., Twardella D. Perfluorinated compounds-exposure assessment for the general population in Western countries. Int. J. Hyg. Environ. Health 2009, 212:239-270.
15. Gazdar A.F., Oie H.K., Shackleton C.H., Chen T.R., Triche T.J., Myers C.E., Chrousos G.P., Brennan M.F., Stein C.A., La Rocca R.V. Establishment and characterization of a human adrenocortical carcinoma cell line that expresses multiple pathways of steroid biosynthesis. Cancer Res. 1990, 50:5488-5496.
16. Gracia T., Hilscherova K., Jones P.D., Newsted J.L., Zhang X., Hecker M., Higley E.B., Sanderson J.T., Yu R.M., Wu R.S., Giesy J.P. The H295R system for evaluation of endocrine-disrupting effects. Ecotoxicol. Environ. Saf. 2006, 65:293-305.
17. Hecker M., Akahori Y., Murphy M., Nelleman C., Highley E., Newsted J.L., Wu R., Lam P., Lasley B., Buckalew A., Grund S., Nakai M., Timm G., Giesy J.P. The OECD validation program of the H295R steroidogenesis assay for the identification of in vitro inhibitors and inducers of testosterone and estradiol production. Phase 2: inter-laboratory pre-validation studies. Environ. Sci. Pollut. Res. 2007, 14:23-30.
18. Hilscherova K., Jones P.D., Gracia T., Newsted J.L., Zhang X., Sanderson J.T., Yu R.M., Wu R.S., Giesy J.P. Assessment of the effects of chemicals on the expression of ten steroidogenic genes in the H295R cell line using real-time PCR. Toxicol. Sci. 2004, 81:78-89.
19. Hu X.Z., Hu D.C. Effects of perfluorooctanoate and perfluorooctane sulfonate exposure on hepatoma Hep G2 cells. Arch. Toxicol. 2009, 83:851-861.
20. Kato K., Wong L.Y., Jia L.T., Kuklenyik Z., Calafat A.M. Trends in Exposure to Polyfluoroalkyl Chemicals in the U.S. Population: 1999-2008. Environ. Sci. Technol. 2011, [E publication ahead of print].
21. Lau C., Thibodeaux J.R., Hanson R.G., Rogers J.M., Grey B.E., Stanton M.E., Butenhoff J.L., Stevenson L.A. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: postnatal evaluation. Toxicol. Sci. 2003, 74:382-392.
22. Lephart E.D., Simpson E.R. Assay of aromatase activity. Methods Enzymol. 1991, 206:477-483.
23. Liu C., Yu K., Shi X., Wang J., Lam P.K., Wu R.S., Zhou B. Induction of oxidative stress and apoptosis by PFOS and PFOA in primary cultured hepatocytes of freshwater tilapia (Oreochromis niloticus). Aquat. Toxicol. 2007, 82:135-143.
24. Liu R.C., Hahn C., Hurtt M.E. The direct effect of hepatic peroxisome proliferators on rat Leydig cell function in vitro. Fundam. Appl. Toxicol. 1996, 30:102-108.
25. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
26. Monroy R., Morrison K., Teo K., Atkinson S., Kubwabo C., Stewart B., Foster W.G. Serum levels of perfluoroalkyl compounds in human maternal and umbilical cord blood samples. Environ. Res. 2008, 108:56-62.
27. Nakata H., Kannan K., Nasu T., Cho H.S., Sinclair E., Takemurai A. Perfluorinated contaminants in sediments and aquatic organisms collected from shallow water and tidal flat areas of the Ariake Sea, Japan: environmental fate of perfluorooctane sulfonate in aquatic ecosystems. Environ. Sci. Technol. 2006, 40:4916-4921.
28. Oakes K.D., Sibley P.K., Martin J.W., MacLean D.D., Solomon K.R., Mabury S.A., Van Der Kraak G.J. Short-term exposures of fish to perfluorooctane sulfonate: acute effects on fatty acyl-coa oxidase activity, oxidative stress, and circulating sex steroids. Environ. Toxicol. Chem. 2005, 24:1172-1181.
29. Oakes K.D., Sibley P.K., Solomon K.R., Mabury S.A., Van Der Kraak G.J. Impact of perfluorooctanoic acid on fathead minnow (Pimephales promelas) fatty acyl-CoA oxidase activity, circulating steroids, and reproduction in outdoor microcosms. Environ. Toxicol. Chem. 2004, 23:1912-1919.
30. Ohmori K., Kudo N., Katayama K., Kawashima Y. Comparison of the toxicokinetics between perfluorocarboxylic acids with different carbon chain length. Toxicology 2003, 184:135-140.
31. Olsen G.W., Burris J.M., Ehresman D.J., Froehlich J.W., Seacat A.M., Butenhoff J.L., Zobel L.R. Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ. Health Perspect. 2007, 115:1298-1305.
32. Olsen G.W., Gilliland F.D., Burlew M.M., Burris J.M., Mandel J.S., Mandel J.H. An epidemiologic investigation of reproductive hormones in men with occupational exposure to perfluorooctanoic acid. J. Occup. Environ. Med. 1998, 40:614-622.
33. Shi Z., Zhang H., Liu Y., Xu M., Dai J. Alterations in gene expression and testosterone synthesis in the testes of male rats exposed to perfluorododecanoic acid. Toxicol. Sci. 2007, 98:206-215.
34. Skakkebaek N.E., Rajpert-De M.E., Main K.M. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum. Reprod. 2001, 16:972-978.
35. Thibodeaux J.R., Hanson R.G., Rogers J.M., Grey B.E., Barbee B.D., Richards J.H., Butenhoff J.L., Stevenson L.A., Lau C. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: maternal and prenatal evaluations. Toxicol. Sci. 2003, 74:369-381.
36. Wei Y., Liu Y., Wang J., Tao Y., Dai J. Toxicogenomic analysis of the hepatic effects of perfluorooctanoic acid on rare minnows (Gobiocypris rarus). Toxicol. Appl. Pharmacol. 2008, 226:285-297.
37. Yamashita N., Kannan K., Taniyasu S., Horii Y., Petrick G., Gamo T. A global survey of perfluorinated acids in oceans. Mar. Pollut. Bull. 2005, 51:658-668.
38. Zimmer K.E., Montano M., Olsaker I., Dahl E., Berg V., Karlsson C., Murk A.J., Skaare J.U., Ropstad E., Verhaegen S. In vitro steroidogenic effects of mixtures of persistent organic pollutants (POPs) extracted from burbot (Lota lota) caught in two Norwegian lakes. Sci. Total Environ. 2011, 409:2040-2048.